• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共生菌治疗婴儿腹绞痛的效果:一项双盲、随机、安慰剂对照临床试验。

The effect of symbiotic in the treatment of infantile colic: A double-blind, randomized, placebo-controlled clinical trial.

作者信息

Khoshnevisasl Parisa, Sadeghzadeh Mansour, Kamali Koorosh, Hasanlo Masoumeh

机构信息

Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.

Department of Pediatrics, Zanjan University of Medical Sciences, Zanjan, Iran.

出版信息

J Res Med Sci. 2022 May 30;27:42. doi: 10.4103/jrms.jrms_128_21. eCollection 2022.

DOI:10.4103/jrms.jrms_128_21
PMID:35968208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9374146/
Abstract

BACKGROUND

This study aims to evaluate the effect of symbiotic (Pedilact) on the treatment of infantile colic.

MATERIALS AND METHODS

In this randomized clinical trial in Zanjan, Iran, 76 infants with infantile colic were assigned to two groups of 38 cases using block randomization. The intervention group received 5 drops of Pedilact, a symbiotic containing and simethicone (20 mg twice daily), and the control group received placebo in addition to simethicone for 4 weeks. Daily crying time, number of crying attacks per day, and sleep duration were recorded on days 1, 7, 14, 21, and 28, and the results were compared.

RESULTS

Thirty-three infants in the intervention group and 35 infants in the control group were enrolled. There was no significant difference between the two groups in terms of age, gender, gestational age, maternal age, type of delivery, type of feeding, and weight at the beginning and the end of the study (all > 0.05). Daily crying time in the control and intervention groups decreased from 240 and 210 min/day, respectively, to 0 min/day in both the groups. Daily crying attacks decreased from 5 and 4/day in the control and intervention groups, respectively, to 0/day. Sleep duration in both the groups increased from 720 to 840 and 930 min/day in the control and intervention groups, respectively, but the changes were not significant ( = 0.56, = 0.52, and = 0.13, respectively).

CONCLUSION

We did not find a significant improvement in colic symptoms in infants receiving symbiotic compared to placebo.

摘要

背景

本研究旨在评估共生菌剂(培迪拉克)对婴儿腹绞痛的治疗效果。

材料与方法

在伊朗赞詹进行的这项随机临床试验中,76例婴儿腹绞痛患儿采用区组随机化方法被分为两组,每组38例。干预组接受5滴培迪拉克(一种含有 和西甲硅油的共生菌剂,西甲硅油20毫克,每日两次),对照组除西甲硅油外还接受安慰剂治疗,为期4周。在第1、7、14、21和28天记录每日哭闹时间、每日哭闹发作次数和睡眠时间,并对结果进行比较。

结果

干预组纳入33例婴儿,对照组纳入35例婴儿。两组在年龄、性别、胎龄、母亲年龄、分娩方式、喂养方式以及研究开始和结束时的体重方面均无显著差异(均P>0.05)。对照组和干预组的每日哭闹时间分别从240分钟/天和210分钟/天降至两组均为0分钟/天。每日哭闹发作次数分别从对照组的5次/天和干预组的4次/天降至0次/天。两组的睡眠时间分别从对照组的720分钟/天增加到840分钟/天,干预组从720分钟/天增加到930分钟/天,但变化不显著(P分别为0.56、0.52和0.13)。

结论

与安慰剂相比,我们未发现接受共生菌剂的婴儿腹绞痛症状有显著改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9306/9374146/c46b7fbcc462/JRMS-27-42-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9306/9374146/c46b7fbcc462/JRMS-27-42-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9306/9374146/c46b7fbcc462/JRMS-27-42-g002.jpg

相似文献

1
The effect of symbiotic in the treatment of infantile colic: A double-blind, randomized, placebo-controlled clinical trial.共生菌治疗婴儿腹绞痛的效果:一项双盲、随机、安慰剂对照临床试验。
J Res Med Sci. 2022 May 30;27:42. doi: 10.4103/jrms.jrms_128_21. eCollection 2022.
2
Effect of Lactobacillus reuteri NCIMB 30351 drops on symptoms of infantile functional gastrointestinal disorders and gut microbiota in early infants: Results from a randomized, placebo-controlled clinical trial.鼠李糖乳杆菌 NCIMB 30351 滴剂对婴幼儿功能性胃肠疾病症状及肠道菌群的影响:一项随机、安慰剂对照临床试验的结果。
Eur J Pediatr. 2024 May;183(5):2311-2324. doi: 10.1007/s00431-024-05473-y. Epub 2024 Mar 1.
3
Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study.罗伊氏乳杆菌(美国典型培养物保藏中心菌株55730)与西甲硅油治疗婴儿腹绞痛的前瞻性随机研究。
Pediatrics. 2007 Jan;119(1):e124-30. doi: 10.1542/peds.2006-1222.
4
Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938.罗特氏乳杆菌 DSM 17938 治疗婴儿绞痛的随机、双盲、安慰剂对照试验。
J Pediatr. 2015 Jan;166(1):74-8. doi: 10.1016/j.jpeds.2014.09.020. Epub 2014 Oct 23.
5
Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial.鼠李糖乳杆菌 DSM 17938 用于管理母乳喂养婴儿的婴儿绞痛:一项随机、双盲、安慰剂对照试验。
J Pediatr. 2013 Feb;162(2):257-62. doi: 10.1016/j.jpeds.2012.08.004. Epub 2012 Sep 14.
6
Crying Time and RORγ/FOXP3 Expression in Lactobacillus reuteri DSM17938-Treated Infants with Colic: A Randomized Trial.罗伊氏乳杆菌DSM17938治疗的患腹绞痛婴儿的哭闹时间及RORγ/FOXP3表达:一项随机试验
J Pediatr. 2018 Jan;192:171-177.e1. doi: 10.1016/j.jpeds.2017.08.062. Epub 2017 Sep 29.
7
Efficacy of CECT7263 for infantile colic treatment: an open-label, parallel, randomised, controlled trial.CECT7263 治疗婴儿肠绞痛的疗效:一项开放标签、平行、随机、对照试验。
Benef Microbes. 2021 Feb 24;12(1):55-67. doi: 10.3920/BM2020.0105. Epub 2020 Dec 22.
8
Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial.罗伊氏乳杆菌对婴儿腹绞痛及腹绞痛引发的母亲抑郁的疗效:一项前瞻性单盲随机试验
Antonie Van Leeuwenhoek. 2015 Jun;107(6):1547-53. doi: 10.1007/s10482-015-0448-9. Epub 2015 Apr 16.
9
Effectiveness and Safety of a Probiotic-Mixture for the Treatment of Infantile Colic: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial with Fecal Real-Time PCR and NMR-Based Metabolomics Analysis.益生菌混合物治疗婴儿绞痛的有效性和安全性:一项基于粪便实时 PCR 和 NMR 代谢组学分析的双盲、随机、安慰剂对照临床试验。
Nutrients. 2018 Feb 10;10(2):195. doi: 10.3390/nu10020195.
10
Oral lactase for infantile colic: a randomized double-blind placebo-controlled trial.口服乳糖酶治疗婴儿绞痛:一项随机双盲安慰剂对照试验。
BMC Pediatr. 2022 Aug 3;22(1):468. doi: 10.1186/s12887-022-03531-8.

本文引用的文献

1
Birth Weight and the Development of Functional Gastrointestinal Disorders in Infants.出生体重与婴儿功能性胃肠疾病的发展
Pediatr Gastroenterol Hepatol Nutr. 2020 Jul;23(4):366-376. doi: 10.5223/pghn.2020.23.4.366. Epub 2020 Jul 3.
2
(ATCC 53103) for the Management of Infantile Colic: A Randomized Controlled Trial.(ATCC 53103)在婴儿绞痛管理中的应用:一项随机对照试验。
Nutrients. 2020 Jun 5;12(6):1693. doi: 10.3390/nu12061693.
3
An overview of systematic reviews of complementary and alternative therapies for infantile colic.
补充和替代疗法治疗婴儿绞痛的系统评价概述。
Syst Rev. 2019 Nov 11;8(1):271. doi: 10.1186/s13643-019-1191-5.
4
Probiotics for management of infantile colic: a systematic review of randomized controlled trials.益生菌用于婴儿腹绞痛的管理:随机对照试验的系统评价
Arch Med Sci. 2018 Aug;14(5):1137-1143. doi: 10.5114/aoms.2017.66055. Epub 2017 Feb 16.
5
Infantile colic.婴儿腹绞痛
Aust Prescr. 2018 Aug;41(4):105-110. doi: 10.18773/austprescr.2018.033. Epub 2018 Aug 1.
6
The New Rome IV Criteria for Functional Gastrointestinal Disorders in Infants and Toddlers.婴幼儿功能性胃肠病的新罗马IV标准
Pediatr Gastroenterol Hepatol Nutr. 2017 Mar;20(1):1-13. doi: 10.5223/pghn.2017.20.1.1. Epub 2017 Mar 27.
7
Exploring hypotheses and rationale for causes of infantile colic.探索婴儿腹绞痛病因的假设及理论依据。
Neurogastroenterol Motil. 2017 Feb;29(2). doi: 10.1111/nmo.12943. Epub 2016 Sep 20.
8
Probiotics for the Management of Infantile Colic.益生菌用于婴儿腹绞痛的管理
J Pediatr Gastroenterol Nutr. 2016 Jul;63 Suppl 1:S22-4. doi: 10.1097/MPG.0000000000001220.
9
The Efficacy and Safety of the Probiotic Bacterium Lactobacillus reuteri DSM 17938 for Infantile Colic: A Meta-Analysis of Randomized Controlled Trials.益生菌罗伊氏乳杆菌DSM 17938治疗婴儿腹绞痛的疗效和安全性:一项随机对照试验的荟萃分析
PLoS One. 2015 Oct 28;10(10):e0141445. doi: 10.1371/journal.pone.0141445. eCollection 2015.
10
Infantile Colic: Recognition and Treatment.婴儿腹绞痛:识别与治疗
Am Fam Physician. 2015 Oct 1;92(7):577-82.